Effects of the putative antipsychotic alstonine on glutamate uptake in acute hippocampal slices

Neurochemistry International

Volumn 61, Issue 7, 2012, Pages 1144-1150

  Herrmann, Ana P ^a   Lunardi, Paula ^a   Pilz, Luísa Klaus ^a   Tramontina, Ana C ^a   Linck, Viviane M ^a   Okunji, Christopher O ^b   Gonçalves, Carlos A ^a   Elisabetsky, Elaine ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b International Centre for Ethnomedicine and Drug Development (InterCEDD)   (Nigeria)

Author keywords

Alstonine; Antipsychotics; Astrocytes; Glutamate uptake; S100B; Schizophrenia

Indexed keywords

6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ALSTONINE; ALTANSERIN; APOMORPHINE; CLOZAPINE; DIZOCILPINE; GLUTAMIC ACID; GLUTATHIONE; HALOPERIDOL; NEUROLEPTIC AGENT; PROTEIN S100B; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN SECRETION; PROTEIN TRANSPORT; RAT; SCHIZOPHRENIA; SOCIAL INTERACTION;

ANIMALS; ANTIPSYCHOTIC AGENTS; GLUTAMIC ACID; HIPPOCAMPUS; MALE; RATS; SECOLOGANIN TRYPTAMINE ALKALOIDS;

ANIMALIA;

EID: 84870059301     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.08.006     Document Type: Article

References (81)

1. B. Ahlemeyer, H. Beier, I. Semkova, C. Schaper, and J. Krieglstein S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay × 3702 Brain Res. 858 2000 121 128
2. J.L. Arriza, S. Eliasof, M.P. Kavanaugh, and S.G. Amara Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance Proc. Natl. Acad. Sci. USA 94 1997 4155 4160
3. H.G. Bernstein, J. Steiner, and B. Bogerts Glial cells in schizophrenia: Pathophysiological significance and possible consequences for therapy Expert Rev. Neurother. 9 2009 1059 1071
4. A. Bortolozzi, L. Díaz-Mataix, M.C. Scorza, P. Celada, and F. Artigas The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity J. Neurochem. 95 2005 1597 1607
5. R.W. Browne, and D. Armstrong Reduced glutathione and glutathione disulfide Methods Mol. Biol. 108 1998 347 352
6. A. Carlsson The neurochemical circuitry of schizophrenia Pharmacopsychiatry 39 Suppl. 1 2006 S10 S14
7. Z. Cohen, I. Bouchelet, A. Olivier, J.G. Villemure, R. Ball, D.B. Stanimirovic, and E. Hamel Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: Molecular and pharmacologic characterization J. Cereb. Blood Flow Metab. 19 1999 908 917
8. L. Costa-Campos, D.R. Lara, D.S. Nunes, and E. Elisabetsky Antipsychotic-like profile of alstonine Pharmacol. Biochem. Behav. 60 1998 133 141
9. L. Costa-Campos, S. Dassoler, A. Rigo, M. Iwu, and E. Elisabetsky Anxiolytic properties of the antipsychotic alkaloid alstonine Pharmacol. Biochem. Behav. 77 2004 481 489
10. L. Costa-Campos, M. Iwu, and E. Elisabetsky Lack of pro-convulsant activity of the antipsychotic alkaloid alstonine J. Ethnopharmacol. 93 2004 307 310
11. D.R. Cotter, C.M. Pariante, and I.P. Everall Glial cell abnormalities in major psychiatric disorders: The evidence and implications Brain Res. Bull. 55 2001 585 595
12. 2+ responses in rat primary astrocyte cultures J. Neurosci. Res. 35 1993 246 256
13. V. de Moura Linck, A. Herrmann, G. Goerck, M. Iwu, C. Okunji, M. Leal, and E. Elisabetsky The putative antipsychotic alstonine reverses social interaction withdrawal in mice Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1449 1452
14. 2C receptor be a new target for therapeutic strategies? Curr. Med. Chem. 13 2006 3069 3081
15. J.S. Diamond Neuronal glutamate transporters limit activation of NMDA receptors by neurotransmitter spillover on CA1 pyramidal cells J. Neurosci. 21 2001 8328 8338
16. K.Q. Do, A.H. Trabesinger, M. Kirsten-Krüger, C.J. Lauer, U. Dydak, D. Hell, F. Holsboer, P. Boesiger, and M. Cuénod Schizophrenia: Glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo Eur. J. Neurosci. 12 2000 3721 3728
17. J. Dunlop, K.L. Marquis, H.K. Lim, L. Leung, J. Kao, C. Cheesman, and S. Rosenzweig-Lipson Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications CNS Drug Rev. 12 2006 167 177
18. W.A. Fairman, R.J. Vandenberg, J.L. Arriza, M.P. Kavanaugh, and S.G. Amara An excitatory amino-acid transporter with properties of a ligand-gated chloride channel Nature 375 1995 599 603
19. J.W. Gawryluk, J.F. Wang, A.C. Andreazza, L. Shao, and L.T. Young Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders Int. J. Neuropsychopharmacol. 14 2011 123 130
20. J.A. Gogos, and D.J. Gerber Schizophrenia susceptibility genes: Emergence of positional candidates and future directions Trends Pharmacol. Sci. 27 2006 226 233
21. G. Gründer, H. Hippius, and A. Carlsson The 'atypicality' of antipsychotics: A concept re-examined and re-defined Nat. Rev. Drug Discov. 8 2009 197 202
22. R. Gysin, R. Kraftsik, J. Sandell, P. Bovet, C. Chappuis, P. Conus, P. Deppen, M. Preisig, V. Ruiz, P. Steullet, M. Tosic, T. Werge, M. Cuénod, and K.Q. Do Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence Proc. Natl. Acad. Sci. USA 104 2007 16621 16626
23. 2+ channels Neurochem. Int. 32 1998 153 162
24. M.B. Hansen, S.E. Nielsen, and K. Berg Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill J. Immunol. Methods 119 1989 203 210
25. J. Hirrlinger, and R. Dringen The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking Brain Res. Rev. 63 2010 177 188
26. W.D. Hirst, N.Y. Cheung, M. Rattray, G.W. Price, and G.P. Wilkin Cultured astrocytes express messenger RNA for multiple serotonin receptor subtypes, without functional coupling of 5-HT1 receptor subtypes to adenylyl cyclase Brain Res. Mol. Brain Res. 61 1998 90 99
27. Y.H. Huang, and D.E. Bergles Glutamate transporters bring competition to the synapse Curr. Opin. Neurobiol. 14 2004 346 352
28. M. Huang, J. Dai, and H.Y. Meltzer 5-HT(2A) and 5-HT(2C) receptor stimulation are differentially involved in the cortical dopamine efflux-studied in 5-HT(2A) and 5-HT(2C) genetic mutant mice Eur. J. Pharmacol. 652 2011 40 45
29. Y.H. Huang, S.R. Sinha, K. Tanaka, J.D. Rothstein, and D.E. Bergles Astrocyte glutamate transporters regulate metabotropic glutamate receptor-mediated excitation of hippocampal interneurons J. Neurosci. 24 2004 4551 4559
30. D.C. Javitt Glutamatergic theories of schizophrenia Isr. J. Psychiatry Relat. Sci. 47 2010 4 16
31. Y. Kanai, and M.A. Hediger Primary structure and functional characterization of a high-affinity glutamate transporter Nature 360 1992 467 471
32. P. Katsel, W. Byne, P. Roussos, W. Tan, L. Siever, and V. Haroutunian Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia Neuropsychopharmacology 36 2011 1171 1177
33. D. Kondziella, E. Brenner, E.M. Eyjolfsson, K.R. Markinhuhta, M.L. Carlsson, and U. Sonnewald Glial-neuronal interactions are impaired in the schizophrenia model of repeated MK801 exposure Neuropsychopharmacology 31 2006 1880 1887
34. D. Kögel, M. Peters, H.G. König, S.M. Hashemi, N.T. Bui, V. Arolt, M. Rothermundt, and J.H. Prehn S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: Clinical implications for the role of S100B in excitotoxic brain injury Neuroscience 127 2004 913 920
35. D.R. Lara, C.S. Gama, P. Belmonte-de-Abreu, L.V. Portela, C.A. Gonçalves, M. Fonseca, S. Hauck, and D.O. Souza Increased serum S100B protein in schizophrenia: A study in medication-free patients J. Psychiatr. Res. 35 2001 11 14
36. M.C. Leite, F. Galland, G. Brolese, M.C. Guerra, J.W. Bortolotto, R. Freitas, L.M. Almeida, C. Gottfried, and C.A. Gonçalves A simple, sensitive and widely applicable ELISA for S100B: Methodological features of the measurement of this glial protein J. Neurosci. Methods 169 2008 93 99
37. J. Lieberman, T. Stroup, J. McEvoy, M. Swartz, R. Rosenheck, D. Perkins, R. Keefe, S. Davis, C. Davis, B. Lebowitz, J. Severe, J. Hsiao Investigators, C.A.T.o.I.E.C. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N. Engl. J. Med. 353 2005 1209 1223
38. 2A/C receptors mediate the antipsychotic-like effects of the putative antipsychotic alstonine Prog. Neuropsychopharmacol. Biol. Psychiatry 36 2012 29 33
39. V.M. Linck, A.P. Herrmann, A.L. Piato, B.C. Detanico, M. Figueiró, J. Flório, M. Iwu, C.O. Okunji, M.B. Leal, and E. Elisabetsky Alstonine as an antipsychotic: Effects on brain amines and metabolic changes Evid. Based Complement. Altern. Med. 2011 2011 1 7
40. S.H. Ling, Y.L. Tang, F. Jiang, A. Wiste, S.S. Guo, Y.Z. Weng, and T.S. Yang Plasma S-100B protein in Chinese patients with schizophrenia: Comparison with healthy controls and effect of antipsychotics treatment J. Psychiatr. Res. 41 2007 36 42
41. +-ATPase is altered by antipsychotic administration Regul. Pept. 129 2005 177 182
42. G.J. Marek, B. Behl, A.Y. Bespalov, G. Gross, Y. Lee, and H. Schoemaker Glutamatergic (N-methyl-d-aspartate receptor) hypofrontality in schizophrenia: Too little juice or a miswired brain? Mol. Pharmacol. 77 2010 317 326
43. D. Matsuzawa, T. Obata, Y. Shirayama, H. Nonaka, Y. Kanazawa, E. Yoshitome, J. Takanashi, T. Matsuda, E. Shimizu, H. Ikehira, M. Iyo, and K. Hashimoto Negative correlation between brain glutathione level and negative symptoms in schizophrenia: A 3T 1H-MRS study PLoS ONE 3 2008 e1944
44. C. Matute, M. Melone, A. Vallejo-Illarramendi, and F. Conti Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics Glia 49 2005 451 455
45. M. Melone, L. Bragina, and F. Conti Clozapine-induced reduction of glutamate transport in the frontal cortex is not mediated by GLAST and EAAC1 Mol. Psychiatry 8 2003 12 13
46. R. Meller, P.J. Harrison, J.M. Elliott, and T.J. Sharp In vitro evidence that 5-hydroxytryptamine increases efflux of glial glutamate via 5-HT(2A) receptor activation Neurosci. Res. 67 2002 399 405
47. H.Y. Meltzer, M. Horiguchi, and B.W. Massey The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment Psychopharmacology 213 2011 289 305
48. A. Merzak, S. Koochekpour, M.P. Fillion, G. Fillion, and G.J. Pilkington Expression of serotonin receptors in human fetal astrocytes and glioma cell lines: A possible role in glioma cell proliferation and migration Brain Res. Mol. Brain Res. 41 1996 1 7
49. J.A. Micó, M.O. Rojas-Corrales, J. Gibert-Rahola, M. Parellada, D. Moreno, D. Fraguas, M. Graell, J. Gil, J. Irazusta, J. Castro-Fornieles, C. Soutullo, C. Arango, S. Otero, A. Navarro, I. Baeza, M. Martínez- Cengotitabengoa, and A. González-Pinto Reduced antioxidant defense in early onset first-episode psychosis: A case-control study BMC Psychiatry 11 2011 26
50. +-dependent glutamate transport J. Biomed. Sci. 12 2005 975 984
51. P. Nardin, A.C. Tramontina, A. Quincozes-Santos, L.S. Tortorelli, P. Lunardi, P.R. Klein, K.M. Wartchow, L.D. Bobermin, C. Gottfried, E. Elisabetsky, and C.A. Gonçalves In vitro S100B secretion is reduced by apomorphine: Effects of antipsychotics and antioxidants Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 1291 1296
52. H. Nishiyama, T. Knopfel, S. Endo, and S. Itohara Glial protein S100B modulates long-term neuronal synaptic plasticity Proc. Natl. Acad. Sci. USA 99 2002 4037 4042
53. T. Ohnuma, S.J. Augood, H. Arai, P.J. McKenna, and P.C. Emson Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia Brain Res. Mol. Brain Res. 56 1998 207 217
54. T. Ohnuma, S. Tessler, H. Arai, R.L. Faull, P.J. McKenna, and P.C. Emson Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus Brain Res. Mol. Brain Res. 85 2000 24 31
55. C.O. Okunji, M.M. Iwu, and Y. Ito Preparative separation of indole alkaloids from the rind of Picralima nitida (Stapf) T. Durand & H. Durand by pH-Zone-refining countercurrent chromatography J. Liq. Chromatogr. Relat. Technol. 28 2005 775 783
56. 2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex Neuropsychopharmacology 31 2006 265 277
57. G.L. Peterson A simplification of the protein assay method of Lowry et al. which is more generally applicable Anal. Biochem. 83 1977 346 356
58. G. Pines, N.C. Danbolt, M. Bjorås, Y. Zhang, A. Bendahan, L. Eide, H. Koepsell, J. Storm-Mathisen, E. Seeberg, and B.I. Kanner Cloning and expression of a rat brain l-glutamate transporter Nature 360 1992 464 467
59. M. Raffa, A. Mechri, L.B. Othman, C. Fendri, L. Gaha, and A. Kerkeni Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 1178 1183
60. M. Rothermundt, U. Missler, V. Arolt, M. Peters, J. Leadbeater, M. Wiesmann, S. Rudolf, K.P. Wandinger, and H. Kirchner Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology Mol. Psychiatry 6 2001 445 449
61. M. Rothermundt, P. Falkai, G. Ponath, S. Abel, H. Bürkle, M. Diedrich, G. Hetzel, M. Peters, A. Siegmund, A. Pedersen, W. Maier, J. Schramm, T. Suslow, P. Ohrmann, and V. Arolt Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF Mol. Psychiatry 9 2004 897 899
62. M. Rothermundt, G. Ponath, T. Glaser, G. Hetzel, and V. Arolt S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia Neuropsychopharmacology 29 2004 1004 1011
63. M. Rothermundt, P. Ohrmann, S. Abel, A. Siegmund, A. Pedersen, G. Ponath, T. Suslow, M. Peters, F. Kaestner, W. Heindel, V. Arolt, and B. Pfleiderer Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol Prog. Neuropsychopharmacol. Biol. Psychiatry 31 2007 361 364
64. C.G. Schipke, I. Heuser, and O. Peters Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex J. Psychiatry Res. 45 2011 242 248
65. A. Schmitt, T. Bertsch, U. Henning, H. Tost, A. Klimke, F.A. Henn, and P. Falkai Increased serum S100B in elderly, chronic schizophrenic patients: Negative correlation with deficit symptoms Schizophr. Res. 80 2005 305 313
66. M.L. Schroeter, H. Abdul-Khaliq, S. Frühauf, R. Höhne, G. Schick, A. Diefenbacher, and I.E. Blasig Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia Schizophr. Res. 62 2003 231 236
67. K.J. Seibt, R. da Luz Oliveira, D.B. Rosemberg, L.E. Savio, E.B. Scherer, F. Schmitz, A.T. Wyse, and C.D. Bonan MK-801 alters Na(+), K (+)-ATPase activity and oxidative status in zebrafish brain: Reversal by antipsychotic drugs J. Neural Transm. 119 2012 661 667
68. N. Segnitz, A. Schmitt, P.J. Gebicke-Härter, and M. Zink Differential expression of glutamate transporter genes after chronic oral treatment with aripiprazole in rats Neurochem. Int. 55 2009 619 628
69. R.E. Smith, V. Haroutunian, K.L. Davis, and J.H. Meador-Woodruff Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia Am. J. Psychiatry 158 2001 1393 1399
70. J. Steiner, M. Walter, M.T. Wunderlich, H.G. Bernstein, B. Panteli, M. Brauner, R. Jacobs, T. Gos, M. Rothermundt, and B. Bogerts A new pathophysiological aspect of S100B in schizophrenia: Potential regulation of S100B by its scavenger soluble RAGE Biol. Psychiatry 65 2009 1107 1110
71. J. Steiner, M.L. Schroeter, K. Schiltz, H.G. Bernstein, U.J. Müller, C. Richter-Landsberg, W.E. Müller, M. Walter, T. Gos, B. Bogerts, and G. Keilhoff Haloperidol and clozapine decrease S100B release from glial cells Neuroscience 167 2010 1025 1031
72. P. Steullet, H.C. Neijt, M. Cuénod, and K.Q. Do Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia Neuroscience 137 2006 807 819
73. J.M. Stone, O.D. Howes, A. Egerton, J. Kambeitz, P. Allen, D.J. Lythgoe, R.L. O'Gorman, M.A. McLean, G.J. Barker, and P. McGuire Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis Biol. Psychiatry 68 2010 599 602
74. T. Storck, S. Schulte, K. Hofmann, and W. Stoffel Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain Proc. Natl. Acad. Sci. USA 89 1992 10955 10959
75. T. Sugai, M. Kawamura, S. Iritani, K. Araki, T. Makifuchi, C. Imai, R. Nakamura, A. Kakita, H. Takahashi, and H. Nawa Prefrontal abnormality of schizophrenia revealed by DNA microarray: Impact on glial and neurotrophic gene expression Ann. N. Y. Acad. Sci. 1025 2004 84 91
76. K. Tanaka, K. Watase, T. Manabe, K. Yamada, M. Watanabe, K. Takahashi, H. Iwama, T. Nishikawa, N. Ichihara, T. Kikuchi, S. Okuyama, N. Kawashima, S. Hori, M. Takimoto, and K. Wada Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1 Science 276 1997 1699 1702
77. A.P. Thomazi, G.F. Godinho, J.M. Rodrigues, F.D. Schwalm, M.E. Frizzo, E. Moriguchi, D.O. Souza, and S.T. Wofchuk Ontogenetic profile of glutamate uptake in brain structures slices from rats: Sensitivity to guanosine Mech. Ageing Dev. 125 2004 475 481
78. A. Vallejo-Illarramendi, M. Torres-Ramos, M. Melone, F. Conti, and C. Matute Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte cultures Glia 50 2005 276 279
79. J. van Os, G. Kenis, and B.P. Rutten The environment and schizophrenia Nature 468 2010 203 212
80. M. Wiesmann, K.P. Wandinger, U. Missler, D. Eckhoff, M. Rothermundt, V. Arolt, and H. Kirchner Elevated plasma levels of S-100b protein in schizophrenic patients Biol. Psychiatry 45 1999 1508 1511
81. J.K. Yao, S. Leonard, and R. Reddy Altered glutathione redox state in schizophrenia Dis. Markers 22 2006 83 93